Morning Market Losers
Synta Pharmaceuticals (NASDAQ: SNTA) shares dipped 32.93% to $4.95 after the company reported positive overall survival results from GALAXY-1 Phase 2b/3 trial of ganetespib in second-line non-small cell lung cancer.
Infinity Pharmaceuticals (NASDAQ: INFI) shares lost 23.41% to $20.64 on Phase 1 data.
Affymax (NASDAQ: AFFY) fell 22.60% to $1.61. Affymax's PEG ratio is -0.17.
National Bank of Greece SA (NYSE: NBG) dropped 12.60% to $6.31. The bank's trailing-twelve-month profit margin is -98.37%
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.